Search
for
Sort by
Research 301–330 of 1000+
- Acne is a medical and social problem
- Dermatological Drugs, Topical Agents, and Cosmetics
- Cicatricial Alopecias
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Retinoids in scarless skin regeneration: from molecular mechanisms to therapeutic strategies
- Lichen Planopilaris
- British Society for Dermatopathology
- Dermatologic therapy: December 1987 to December 1988
- Dermatologia e Procedimentos Estéticos Ed. XXVII
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- The most common trichological problems of the scalp
- Carbon‐dioxide laser‐associated PDT treatment of folliculitis decalvans
- Anti-acne drugs in phase 1 and 2 clinical trials
- Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib
- Responsive Microneedles as a New Platform for Precision Immunotherapy
- Hidradenitis Suppurativa and Wound Management
- Ethosome: a novel vesicular carrier for transdermal drug delivery
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial
- Acne Syndromes and Mosaicism
- Ichthyosis
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Inherited ichthyoses/generalized Mendelian disorders of cornification
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Dermatological problems of the puberty
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- Congenital milia En plaque on scalp
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology